Novo Nordisk: Clinical Trials & Research Profile
Biopharma Industry (Bagsvaerd, DK / Plainsboro, NJ) · Primary Focus: Endocrinology, Obesity, and Metabolic
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Bagsvaerd, DK / Plainsboro, NJ) |
| Primary Therapeutic Area | Endocrinology, Obesity, and Metabolic |
| Active Phase II & III Studies | 60 active (31 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 176 (130 with California sites) |
| Completed vs Early-Stopped Studies | 104 completed / 12 stopped (6.8% stop rate) |
| Median Closed Enrollment | 300 participants |
| FDA Drugs@FDA Original Approvals | 20 all-time (5 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 95.3% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Novo Nordisk across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk